Anthera Pharmaceuticals, Inc. (ANTH)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Jan 17, 2025, 4:00 PM EST
Anthera Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | 2012 - 2008 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '18 Mar 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | 2012 - 2008 |
| Net Income | -23.39 | -26.87 | -55.52 | -35.22 | -29.6 | -30.86 | Upgrade
|
| Depreciation & Amortization | 0.4 | 0.28 | 0.27 | 0.29 | 0.34 | 0.35 | Upgrade
|
| Other Amortization | - | - | - | - | 0.45 | 1.17 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | 0.01 | Upgrade
|
| Stock-Based Compensation | 6.6 | 4.38 | 6.74 | 3.54 | 2.18 | 3.15 | Upgrade
|
| Other Operating Activities | -13.53 | -9.64 | -1.74 | - | 1 | - | Upgrade
|
| Change in Accounts Receivable | 0.1 | - | 0.33 | -0.33 | - | - | Upgrade
|
| Change in Accounts Payable | -1.02 | -2.95 | -0.48 | 3.03 | -1.21 | -1.83 | Upgrade
|
| Change in Unearned Revenue | - | - | -0.14 | -2.56 | - | - | Upgrade
|
| Change in Other Net Operating Assets | -1.1 | -2.09 | 1.63 | 0.35 | 1.25 | -3.9 | Upgrade
|
| Operating Cash Flow | -31.95 | -36.9 | -48.92 | -30.91 | -25.6 | -31.91 | Upgrade
|
| Capital Expenditures | - | - | -0.77 | -0.08 | - | -0.02 | Upgrade
|
| Investment in Securities | - | - | - | - | - | 5.33 | Upgrade
|
| Other Investing Activities | - | - | - | - | 10 | -10 | Upgrade
|
| Investing Cash Flow | 0.36 | - | -0.77 | -0.08 | 10 | -4.69 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 19.8 | Upgrade
|
| Total Debt Issued | - | - | - | - | - | 19.8 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -18.09 | -22.44 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | - | -18.09 | -2.64 | Upgrade
|
| Issuance of Common Stock | 19.03 | 18.25 | 6.73 | 75.3 | 10.39 | 45.79 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | - | -0.03 | Upgrade
|
| Other Financing Activities | - | - | -0.16 | - | - | - | Upgrade
|
| Financing Cash Flow | 19.03 | 18.25 | 23.58 | 75.3 | -7.71 | 43.12 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | - | -0 | Upgrade
|
| Net Cash Flow | -12.57 | -18.65 | -26.11 | 44.31 | -23.31 | 6.52 | Upgrade
|
| Free Cash Flow | -31.95 | -36.9 | -49.69 | -30.99 | -25.6 | -31.93 | Upgrade
|
| Free Cash Flow Margin | - | - | -34265.52% | -972.90% | - | - | Upgrade
|
| Free Cash Flow Per Share | -2.26 | -3.59 | -9.62 | -6.96 | -9.41 | -13.98 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 0.66 | 2.48 | Upgrade
|
| Levered Free Cash Flow | -17.92 | -23.15 | -28.29 | -16.09 | -14.54 | -19.2 | Upgrade
|
| Unlevered Free Cash Flow | -17.92 | -23.15 | -28.29 | -16.09 | -14.33 | -18.74 | Upgrade
|
| Change in Net Working Capital | 1.91 | 5.04 | -1.2 | -2.19 | -0.94 | 4.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.